描述
Tocilizumab Injection is a 400mg/20ml sterile injectable monoclonal antibody developed and manufactured by Bai’aoTai Biopharmaceutical Co., Ltd. This product is designed for research use only, primarily targeting the interleukin-6 (IL-6) receptor to explore inflammatory pathways, autoimmune diseases, and cytokine signaling mechanisms.
Tocilizumab is widely studied in immunology and inflammatory disease research, including models of rheumatoid arthritis, cytokine release syndrome, and other IL-6 mediated conditions.
This injectable formulation provides a consistent, high-purity preparation suitable for in vitro and in vivo experimental applications.
Product Parameters
Parameter | Details |
---|---|
Product Name | Tocilizumab Injection |
Dosage Form | Injectable solution |
Specification | 400mg per 20ml vial |
Approval Number | S20230001 |
Drug Standard Code | 86982116000061 |
Manufacturer | Bai’aoTai Biopharmaceutical Co., Ltd. |
Packaging Unit | 1 vial/box |
Barcode | 6972396420264 |
Intended Use | Research only; not for clinical or human use |
Mechanism of Action
Tocilizumab is a humanized monoclonal antibody that specifically targets the interleukin-6 (IL-6) receptor. By binding to both soluble and membrane-bound IL-6 receptors, it inhibits IL-6-mediated signaling pathways. This blockade reduces inflammation and modulates immune responses, making it effective in treating autoimmune diseases and inflammatory conditions.
Core Keywords
Tocilizumab injection, IL-6 receptor antibody, monoclonal antibody injection, tocilizumab 400mg, cytokine research drug, inflammatory disease research, rheumatoid arthritis model, laboratory use only, wholesale tocilizumab
Research Use Disclaimer
This product is for laboratory and research purposes only. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals. Please handle according to your institutional safety protocols.
评价
目前还没有评价